Metraipolis › archive › dc_3840bb558534

Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors — Europe PMC PMID:42244520

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42244520
DOI
10.1093/narcan/zcag013
License (as archived)
solo-consultazione
Archived
2026-10-07T23:30:16.781Z
SHA-256 of the archived text
0437d3bcb88aa3875bcb9328de3efbfb4e1ae20efef9fdf32dc3dcf293b94e0c
Stable URL of this page
https://metraipolis.com/documento/dc_3840bb558534

How to cite

Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors — Europe PMC PMID:42244520 — Europe PMC (en), https://europepmc.org/article/MED/42244520 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3840bb558534 (Metraipolis archive dc_3840bb558534, sha256 0437d3bcb88aa3875bcb9328de3efbfb4e1ae20efef9fdf32dc3dcf293b94e0c)
BibTeX
@misc{dc3840bb558534,
  title = {Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors — Europe PMC PMID:42244520},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42244520},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3840bb558534; sha256 0437d3bcb88aa3875bcb9328de3efbfb4e1ae20efef9fdf32dc3dcf293b94e0c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42244520. Agents can read the archived copy with the MCP tool read_document.